Reactions Weekly

, Volume 1688, Issue 1, pp 136–136 | Cite as

Ipilimumab/nivolumab/pembrolizumab

Various toxicities: 2 case reports
Case report
  • 17 Downloads

Reference

  1. Schliep S, et al. Concealed complete response in melanoma patients under therapy with immune checkpoint inhibitors: Two case reports. Journal for ImmunoTherapy of Cancer 6: 2, No. 1, 15 Jan 2018. Available from: URL: http://doi.org/10.1186/s40425-017-0309-3 - GermanyCrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations